Health

Ending autoimmune disease? ‘Inverse vaccination’ and unlearning immune response

Autoimmune diseases severely impact more than 50 million Americans, and there has been a worrying increase in cases in recent years, according to the Autoimmune Association. These diseases are caused by an attack from our very own immune system. Immune cells called T cells are often involved in a faulty immune response — as their

Ending autoimmune disease? ‘Inverse vaccination’ and unlearning immune response Read More »

Genetic interventions in Alzheimer’s disease: A promising future

According to a 2021 report by Alzheimer’s Disease International, someone in the world develops dementia every three seconds. It is an extremely common disease and diagnoses will only become more frequent; over 30 years, the number of people with dementia is expected to grow by 84 million. Alzheimer’s disease alone accounts for 80% of dementia

Genetic interventions in Alzheimer’s disease: A promising future Read More »

Crystal clear: Acrylic skull windows revolutionize post-craniectomy recovery

Tucker Marr, an avid hockey player and analyst at Deloitte, suffered a fractured right skull and a subdural hematoma after falling down a flight of stairs. These injuries are critical and warrant emergency surgical treatment, a procedure called a craniectomy. Craniotomies are performed to reduce swelling, pressure, or bleeding in the brain, all of which

Crystal clear: Acrylic skull windows revolutionize post-craniectomy recovery Read More »

Opinion: The invisible pill

As patients, doctors have earned our trust and attention. We choose them based on experience, recommendation, or prestige, but ultimately, we put our care in their hands. Despite this trust, we expect to maintain free will when deciding to continue or decline treatment. For those with exacerbated neurodegenerative diseases and various mental disorders, would you

Opinion: The invisible pill Read More »

Oral phenylephrine: placebo, in tablet form

On Sept. 12, 2023, an FDA advisory committee concluded that over-the-counter (OTC) oral phenylephrine — the main active ingredient in Sudafed PE — is ineffective as a treatment for nasal congestion. This finding did not strike healthcare practitioners as “especially surprising” given that its efficacy has been controversial for decades. Despite this, the ingredient is

Oral phenylephrine: placebo, in tablet form Read More »